Uganda's health ministry yesterday reported that Ebola has spread to Jinja district in the southeastern part of the country (see Google Maps image below).
A study today in BMC Medicine highlights the toll that the COVID-19 pandemic has taken on the diagnosis of tuberculosis (TB) in high-burden countries, particularly in vulnerable populations.
A UK study suggests that Omicron BA.2 is tied to more symptoms and impeded daily activities than BA.1, and Taiwanese researchers describe fatal cerebral edema in 6 kids with BA.2.
The sensitivities of 3 commonly used rapid antigen tests were very low for Omicron in asymptomatic people.
A study of 2,126 vaccine recipients identifies 10 cardiac events that all had alternative explanations, and no hospitalizations.
Flu activity in the Northern Hemisphere is rising, with levels up sharply over the past few weeks in North America, the World Health Organization (WHO) said yesterday in its latest global flu update, which roughly covers the last half of October.
The findings suggest the drug could be part of a shorter and simpler tuberculosis treatment regimen.
The percentage of kids receiving 5 to 7 days of antibiotics rose from the baseline of 60% to 86%.
Uganda has reported one more lab-confirmed Ebola infection, which involves a 23-year-old woman who is a healthcare worker in Mubende, one of the outbreak's hot spots, according to an update yesterday from the World Health Organization (WHO) Uganda office.
Relative vaccine effectiveness of a second booster dose against severe COVID-19 is only about 30% after 2 to 4 months in people 80 and older, compared with one booster dose.
US adults who get the flu vaccine every year are 24.7% more likely to complete a primary COVID-19 vaccine regimen.
The Maricopa County Department of Public Health (MCDPH) in Arizona this week reported a dengue infection in someone who was probably exposed to an infected mosquito in Maricopa County.
Mosquito surveillance has detected dengue virus in a mosquito trap in one of the county's neighborhood, the MCDPH said in a Nov 14 press release.
Flu vaccination reduced pneumonia by 40% and hospitalization by 15% in people with heart failure.
District officials in the latest affected area of Uganda reported two more Ebola cases that involve family members of a recently confirmed case-patient in Jinja, according to the Monitor, a Kampala-based newspaper, reported today.
From 53% to 74% of students were able to end isolation early, but 15% to 22% tested positive beyond the recommended isolation period.
At a routine press briefing today, two White House officials fielded questions about President Joe Biden's recent off-the-cuff comment during a news program that the pandemic is over, while acknowledging that COVID is still a problem.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
A new report from Scotland's national health service shows that three key healthcare-associated infections remained stable or declined from 2020 to 2021.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
A study in The Lancet Infectious Diseases demonstrates that previous Omicron BA.1 infection was the most protective factor against BA.2 infection (associated with a risk reduction of 72%) and gave greater protection than primary infection with pre-Omicron SARS-CoV-2 (38%) or three doses of an mRNA vaccine in people with no previous infection (46%).
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
Swiss biopharmaceutical company Ferring Pharmaceuticals announced yesterday that the Food and Drug Administration's (FDA's) Vaccine and Related Biologic Products Advisory Committee (VRBPAC) voted in favor of the company's investigational fecal microbiota transplant (FMT)-based therapy.
The risk of a range of neurologic conditions rose significantly in the year after COVID-19 infection among a group of US veterans—regardless of whether they had required hospitalization, according to a study published yesterday in Nature Medicine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A new study based on COVID-19 patients in France shows high reinfection rates among people with different Omicron subvariants, including BA.1, BA.2, and BA.5. The study is published as a research letter in Emerging Infectious Diseases.
